These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7445281)

  • 1. Intermittent thiazide therapy in recurrent stone formers.
    Rundle JS; Scott R
    Urology; 1980 Nov; 16(5):464-6. PubMed ID: 7445281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L; Hellgren E
    Br J Urol; 1984 Jun; 56(3):255-62. PubMed ID: 6399984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Odlind B; Wikström B
    J Urol; 1982 Jun; 127(6):1207-10. PubMed ID: 7087040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
    Jorgensen FS; Brünner S
    Scand J Urol Nephrol; 1974; 8(2):128-31. PubMed ID: 4838924
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic management of upper urinary tract stone disease in 172 subjects.
    Scott R; Lewi H
    Urology; 1989 Apr; 33(4):277-81. PubMed ID: 2648657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical studies in calcium oxalate stone formers, with special reference to the effects of thiazide treatment.
    Ahlstrand C
    Scand J Urol Nephrol Suppl; 1984; 81():1-93. PubMed ID: 6387895
    [No Abstract]   [Full Text] [Related]  

  • 8. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones.
    Mortensen JT; Schultz A; Ostergaard AH
    Int Urol Nephrol; 1986; 18(3):265-9. PubMed ID: 3533825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of low-dose thiazide and amiloride administration in recurrent renal stone formers.
    Maschio G; D'Angelo A; Fabris A; Tessitore N; Sartori L; Morbiato F; Malvasi L; Giannini S; Ferrari S; Rugiu C
    Contrib Nephrol; 1985; 49():108-17. PubMed ID: 3830560
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of drug therapy efficacy to prevent recurrence of calcium oxalate kidney stone formation.
    Sarig S; Garti N; Azoury R; Perlberg S; Wax Y
    J Urol; 1983 Jun; 129(6):1258-61. PubMed ID: 6854813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in renal papillary density after hydration therapy in calcium stone formers.
    Ferraro PM; Vittori M; Macis G; D'Addessi A; Lombardi G; Palmisano C; Gervasoni J; Primiano A; Bassi PF; Gambaro G
    BMC Urol; 2018 Nov; 18(1):101. PubMed ID: 30419887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.